Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233


Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).

Hong H, Dragan Y, Epstein J, Teitel C, Chen B, Xie Q, Fang H, Shi L, Perkins R, Tong W.

BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S5.


Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.

Cairns DA, Perkins DN, Stanley AJ, Thompson D, Barrett JH, Selby PJ, Banks RE.

BMC Bioinformatics. 2008 Dec 4;9:519. doi: 10.1186/1471-2105-9-519.


Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).

O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.

Clin Invest Med. 2006 Jun;29(3):136-45.


Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.

BMC Cancer. 2005 Jul 20;5:83.


Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R.

Breast Cancer Res. 2008;10(3):R48. doi: 10.1186/bcr2101.


Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.

de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP.

Arthritis Rheum. 2005 Dec;52(12):3801-12.


Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L.

Clin Chem. 2005 Jan;51(1):102-12.


SELDI-TOF-MS of saliva: methodology and pre-treatment effects.

Schipper R, Loof A, de Groot J, Harthoorn L, Dransfield E, van Heerde W.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):45-53.


Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.

Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ.

J Zhejiang Univ Sci B. 2006 Mar;7(3):235-40.


Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.

Geng T, Seitz PK, Thomas ML, Xu B, Soman KV, Kurosky A, Luxon BA, Cunningham KA.

J Neurosci Methods. 2006 Nov 15;158(1):1-12.


Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.

Strenziok R, Hinz S, Wolf C, Conrad T, Krause H, Miller K, Schrader M.

World J Urol. 2010 Apr;28(2):193-7. doi: 10.1007/s00345-009-0434-9.


Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.

Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH.

Jpn J Clin Oncol. 2010 Apr;40(4):336-42. doi: 10.1093/jjco/hyp175.


Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.


Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.

Wang Q, Shen J, Li ZF, Jie JZ, Wang WY, Wang J, Zhang ZT, Li ZX, Yan L, Gu J.

BMC Cancer. 2009 Aug 19;9:287. doi: 10.1186/1471-2407-9-287.


SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.

Geng X, Wang F, Li YG, Zhu GP, Zhang WM.

J Exp Clin Cancer Res. 2007 Dec;26(4):505-8.

Items per page

Supplemental Content

Support Center